Siglec-1 on dendritic cells mediates SARS-CoV-2 trans-infection of target cells while on macrophages triggers proinflammatory responses
Perez-Zsolt, D.; Munoz Basagoiti, J.; Rodo, J.; Elousa, M.; Raich Regue, D.; Risco, C.; Sachse, M.; Pino, M.; Gumber, S.; Paiardini, M.; Chojnacki, J.; Erkizia, I.; Muniz, X.; Ballana, E.; Riveira Munoz, E.; Noguera-Julian, M.; Paredes, R.; Trinite, B.; Tarres Freixas, F.; Blanco, I.; Guallar, V.; Carrillo, J.; Blanco, J.; Telenti, A.; Heyn, H.; Segales, J.; Clotet, B.; Martinez-Picado, J.; Vergara-Alert, J.; Izquierdo-Useros, N.
Show abstract
COVID-19 pandemic is not yet under control by vaccination, and effective antivirals are critical for preparedness. Here we report that macrophages and dendritic cells, key antigen presenting myeloid cells (APCs), are largely resistant to SARS-CoV-2 infection. APCs effectively captured viruses within cellular compartments that lead to antigen degradation. Macrophages sense SARS-CoV-2 and released higher levels of cytokines, including those related to cytokine storm in severe COVID-19. The sialic acid-binding Ig-like lectin 1 (Siglec-1/CD169) present on APCs, which interacts with sialylated gangliosides on membranes of retroviruses or filoviruses, also binds SARS-CoV-2 via GM1. Blockage of Siglec-1 receptors by monoclonal antibodies reduces SARS-CoV-2 uptake and transfer to susceptible target cells. APCs expressing Siglec-1 and carrying SARS-CoV-2 are found in pulmonary tissues of non-human primates. Single cell analysis reveals the in vivo induction of cytokines in those macrophages. Targeting Siglec-1 could offer cross-protection against SARS-CoV-2 and other enveloped viruses that exploit APCs for viral dissemination, including those yet to come in future outbreaks.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages 97%
- Antiviral function and viral antagonism of the rapidly evolving dynein activating adapter NINL 96%
- HIV-1 uncoating by release of viral cDNA from capsid-like structures in the nucleus of infected cells. 96%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- The genetic driver of Acute Necrotizing Encephalopathy, RANBP2, regulates the inflammatory response to Influenza A virus infection 97%
- The S1/S2 boundary of SARS-CoV-2 spike protein modulates cell entry pathways and transmission 96%
- Identification of DAXX As A Restriction Factor Of SARS-CoV-2 Through A CRISPR/Cas9 Screen 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.